Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1/2 3Phase 1 3Phase NA 1Phase 4 1

Status

Completed 31Terminated 5Unknown 3Withdrawn 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 51fludarabine 38Injections 32Gemcitabine 25Paclitaxel 24Cisplatin 22Radiotherapy 19toripalimab 18pembrolizumab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 14Nivolumab 14Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Immunotherapy, Adoptive 11Cetuximab 11Bevacizumab 10Irinotecan 9Drug Therapy 9sintilimab 8Etoposide 8aldesleukin 7Taxes 7Rituximab 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Afatinib × Clear all
NCT03827070 2023-04-25

DPTA

Center Trials & Treatment Europe

Phase 1 Unknown
12 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04448379 2020-12-28

Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer

Shanghai JMT-Bio Inc.

Phase 1 Unknown
48 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02975141 2018-08-13

AFFECT

Ludwig-Maximilians - University of Munich

Phase 1 Unknown
12 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡